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The past two decades have seen significant and
unprecedented progress in human genetics owing
to the advent of novel molecular biological technol-
ogies and major developments in computational
methods. Dermatology has benefited from and, in
some cases, led these advances. In this article, we
review major discoveries in the field of inherited hair
diseases, which illustrate the changes that genoder-
matology has undergone in recent years from a mostly
descriptive discipline through the elucidation of the
molecular basis of numerous disorders, up to the first
attempts at translating these new findings into novel
preventive and therapeutic tools to the benefit of our
patients.
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INHERITED SKIN DISORDERS THROUGH TIME
During the past 20 years, major breakthroughs in genomic
techniques have facilitated considerable progress toward
unraveling the molecular basis of inherited skin diseases
(Figure 1). At present, over 6,000 Mendelian disorders are
known, of which B560 involve skin abnormalities and are
associated with more than 500 unique protein-coding genes
(Feramisco et al., 2009). The successful identification of a
growing number of genes and pathogenic mutations respon-
sible for monogenic skin disorders has had a profound impact
on the field of clinical genetics. First, coupled with functional
studies, gene discovery constitutes an indispensable tool to
understand disease pathogenesis and to indirectly gain insight
into the functions of encoded proteins in normal skin
homeostasis. Second, it provides advances in disease
classification, by merging diseases that manifest with slightly
different phenotypes into a physiological grouping that
harbors unique entities at the molecular level. The simplifica-
tion of disease categorization and elimination of redundant
terminology has implications for the improvement of
diagnostic accuracy, optimization of genetic counseling,
and sets the stage for the development of therapeutic and
preventive approaches for these genodermatoses (McGrath,
2004). A major translational benefit of molecular research in
dermatology is the feasibility and development of prenatal
diagnosis for couples at risk of recurrence of severe inherited
skin diseases, such as the lethal skin blistering disease
epidermolysis bullosa or disorders manifesting with mild
dermatological phenotypes, but heralding severe extracuta-
neous features such as blindness in hypotrichosis with
juvenile macular dystrophy (HJMD; Online Mendelian
Inheritance in Man (OMIM) 601553) and life-threatening
arrhythmias in Naxos disease (OMIM 601214). Prenatal
testing for genodermatoses has been performed since the
1980s, based initially on mid-trimester fetal skin biopsies,
later on DNA-based methods at B10–12 weeks of gestation,
and more recently on preimplantation genetic screening
(Fassihi and McGrath, 2010).
Gene identification in the early days was laborious, and
relied mainly on two main approaches: positional cloning
and candidate gene analysis, as well as extensive clinical
observation and familial segregation of the disease. The first
successful application of this approach led to the delineation
of the molecular basis of X-linked ichthyosis (OMIM 308100)
in 1987. This discovery stemmed from a number of initial
studies including X-linked ichthyosis mapping to chromo-
some X 20 years before the characterization of the underlying
molecular defect (Kerr and Wells, 1964). The fact that
offspring of individuals with the placental sulfatase deficiency
syndrome also presented with ichthyosis pointed to the STS
(steroid sulfatase) gene as a likely candidate (Shapiro et al.,
1978). Finally, large deletions at the STS locus were identified
by using an STS clone isolated from a complementary DNA
library as the probe for Southern blot hybridizations (Ballabio
et al., 1987; Yen et al., 1987). In the early 1990s, similarly
designed studies using a combination of genetic linkage
studies, ultrastructural analysis of skin biopsies, and reverse
genetics led to the elucidation of the molecular basis of a
large number of important genodermatoses, including epi-
dermolysis bullosa simplex (OMIM 131760) caused by
mutations in the KRT5 and KRT14 genes (Bonifas et al.,
1991; Coulombe et al., 1991; Lane et al., 1992) and
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autosomal recessive congenital ichthyosis (OMIM 242300)
caused by mutations in TGM1 (Huber et al., 1995). Later in
the 1990s, structural analysis of anchoring fibrils in patients
with different forms of dystrophic epidermolysis bullosa,
coupled with linkage studies using restriction fragment length
polymorphisms, also resulted in the discovery of mutations
underlying the dystrophic forms of epidermolysis bullosa
(Ryynanen et al., 1992; Christiano et al., 1993; Hilal et al.,
1993). Restriction fragment length polymorphism analysis,
which involves restriction digestions followed by Southern
blotting, was the first DNA-based technique used in genomic
mapping, disease-associated gene mapping, as well as
determination of disease risk and paternity testing. Owing
to the transformative discovery of PCR and the emergence of
inexpensive DNA sequencing technologies, this cumbersome
technique has been largely replaced by PCR-based linkage
methods such as short tandem repeat analysis. This method
consists of the PCR amplification of short tandem repeats (or
microsatellites), which are units of 2–13 nucleotides that are
repeated hundreds of times in a row on a DNA strand, to
resolve their segregation patterns within families.
The completion of the human genome project in 2003
marked a crucial turning point in modern genetics research.
At present, genome-wide techniques, such as genotyping
arrays and next-generation sequencing (NGS), are available
and are complementing or replacing traditional methods.
Genotyping array technology, which allows the genotype
determination of 104 to 2106 single-nucleotide polymor-
phisms simultaneously, is currently widely used for linkage
analysis because it is faster and allows generation of much
denser linkage maps than the traditional microsatellite-based
linkage analysis. The main weakness of this method is the
need for large pedigrees with several affected individuals to
achieve statistical significance. This problem is mainly of
relevance in the study of autosomal dominant disorders.
Autosomal recessive conditions can usually be solved more
easily in small consanguineous families exhibiting identity by
descent using homozygosity mapping (Alkuraya, 2010).
Whole-exome and whole-genome sequencing are now
available to study disorders that are not amenable to linkage
analysis, because of small family size, for example. Whereas
whole-exome sequencing is powerful to identify mutations in
the coding region and splice-site mutations (which account
for most monogenic diseases), whole-genome sequencing
allows the additional identification of mutations in nontrans-
lated regions and other regulatory elements (Ku et al., 2011).
These novel techniques have already been proven successful
in identifying new pathogenic mutations in skin diseases. For
example, a mutation in ADAM17 underlying an autosomal
recessive inflammatory skin and bowel disease was very
recently identified using a combination of homozygosity
genome-wide single-nucleotide polymorphism mapping and
targeted sequence capture, followed by NGS (Blaydon et al.,
2011). This exciting new era looks promising to elucidate the
genetic cause of over 3,000 monogenic disorders, the cause
of which remains currently unknown.
FROM PHENOMICS TO GENETICS: HAIR DISORDERS AS
AN EXAMPLE
Careful phenotypic characterization is immensely important
for the successful identification of causative genes in
inherited disorders in general, and in genodermatoses more
specifically. In turn, the elucidation of the genetic under-
pinning of a given phenotype often reveals genotype–pheno-
type correlations of potential use for the reclassification of
clinical entities and their treatment.
Inherited hair disorders are no exception to this rule. More
than 300 inherited disorders featuring hair abnormalities have
been cataloged to date, and yet, in a substantial portion of
these, no genetic defect has been identified. These disorders
are, as a group, often extraordinarily challenging from a
diagnostic point of view because of a high degree of
phenotypic overlap. Many classifications have been put
forward in an attempt to facilitate their diagnosis (Sprecher,
2005; Schweizer et al., 2007; Cheng and Bayliss, 2008).
Genetically determined abnormal hair growth can either
manifest as excess of hair (hypertrichosis) or lack of hair
(hypotrichosis/alopecia/atrichia). Disorders characterized by
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Figure 1. DNA milestones timeline. Major discoveries and breakthroughs in genomic technologies over the past 50 years are shown, which have
allowed the enormous advances in the field of inherited skin diseases as well as many other hereditary disorders. cDNA, complementary DNA;
HD, Huntington disease; RFLP, restriction fragment length polymorphism; RNAi, RNA interference.
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excess of hair are known as hypertrichoses, which can
manifest either in a generalized or localized manner. It is
interesting to note that most inherited forms of generalized
hypertrichosis have been shown to result from complex
chromosomal rearrangements, which has led some authors to
suggest that they may be better viewed as genomic rather
than genetic disorders (Fantauzzo et al., 2008; Sun et al.,
2009; Zhu et al., 2011). Most types of localized hyper-
trichoses are, in contrast, part of complex syndromes and are
due to discrete sequence alterations, as exemplified by the
recently described ‘‘H’’ syndrome, due to mutations in the
SLC29A3 gene (Molho-Pessach et al., 2008).
Hair disorders associated with sparse hair can grossly be
characterized into two major groups according to the absence
(nonsyndromic) or presence (syndromic) of extracutaneous
features. For example, children with hypotrichosis inherited
in an autosomal recessive manner can either display short
and sparse hair in isolation (Kazantseva et al., 2006) or in
association with nondermatological features such as retinal
degeneration in HJMD (Souied et al., 1995), lymphedema in
hypotrichosis–lymphedema–telangiectasia syndrome (OMIM
607883; Irrthum et al., 2003), and severe immunodeficiency
in T-cell immunodeficiency, congenital alopecia, and nail
dystrophy syndrome (OMIM 601705; Frank et al., 1999).
These two groups of disorders can be further subdivided into
diseases associated with scarring alopecias, as in ichthyosis
follicularis, alopecia, and photophobia syndrome (OMIM
308205), caused by mutations in the MBTPS2 gene (Oeffner
et al., 2009), or nonscarring alopecias. Non-scarring alopecias
can in turn be subclassified into three classes of disorders
characterized by a total absence of hair (atrichia), as exempli-
fied by atrichia with papular lesions (APL; OMIM 209500), or
a paucity of hair (hypotrichosis), as seen in hypotrichosis
simplex of the scalp (OMIM 146520) or abnormal hair shaft
structure, as in monilethrix (OMIM 158000) or Netherton
syndrome (OMIM 256500; Figure 2).
This phenotypic classification has served as a conceptual
framework for an international effort that has led over the past
years to the elucidation of the molecular basis of most major
forms of inherited hair disorders. These achievements have
in turn radically changed our understanding of fundamental
aspects of hair biology while also allowing for prenatal
diagnosis (where appropriate) and paving the way for novel
therapeutic interventions. The following section encapsulates
three lines of research that illustrate these principles.
FROM MONOGENIC DISEASES TO HAIR BIOLOGY:
THREE SHORT STORIES
Hairless-associated disorders
APL (OMIM 209500) is characterized by early-onset and
complete hair loss, upon which small erythematous papules
appear over most parts of the skin surface, because of the
development of dermal cysts after a defective first catagen
phase of the hair cycle (Figure 3). Homozygous loss-of-
function mutations in the hairless (HR) gene were found to
cause APL in humans (Ahmad et al., 1998; Cichon et al., 1998;
Sprecher et al., 1999), as well as related phenotypes in various
animals (Cachon-Gonzalez et al., 1999; Ahmad et al., 2002).
Human and mouse hairless proteins have highly homo-
logous amino-acid sequences, which suggest high conserva-
tion and functional importance of hairless. This protein is a
potential zinc-finger transcription factor that harbors a
jumonji C domain, which is a structural domain contained
by histone demethylases. Accordingly, hairless was recently
shown experimentally to display histone demethylase func-
tion, and therefore may have a role in the epigenetic
regulation of the hair cycle (Shimomura and Christiano,
2010; Liu et al., 2011).
Several lines of evidence indicate that hairless function is
necessary for hair cycling, but not for hair follicle morpho-
genesis. Hairless is an important regulator of the catagen
phase, including processes such as club hair formation,
maintenance of dermal papilla–epithelial integrity, inner root
sheath disintegration, and keratinocyte apoptosis in the hair
follicle matrix (Panteleyev et al., 2000). Interestingly, muta-
tions in the VDR (vitamin D receptor) gene result in a hair
scalp phenocopy of APL (Hughes et al., 1988), reflecting the
fact that hairless function is, in part, dependent on its
interaction with VDR (Skorija et al., 2005).
In addition to APL and related recessive phenotypes, Marie
Unna hereditary hypotrichosis (MUHH; OMIM 146550),
a dominant form of hypotrichosis, was also mapped to
the hairless locus 10 years ago. Individuals with MUHH are
born with sparse scalp, body, and facial hair (including
eyebrows and eyelashes). In early childhood, they develop
coarse, wiry, twisted hair, followed by the progressive
development of alopecia at puberty. Total alopecia or bald
lesions resembling androgenetic alopecia can be observed
later in life.
MUHH was initially mapped to chromosome 8p, in a
region containing the hairless gene, using a genome-wide
linkage approach in a large Dutch family (van Steensel et al.,
1999). Several studies further confirmed linkage of the
disease to chromosome 8p21 (Lefevre et al., 2000; Sreekumar
et al., 2000; He et al., 2004). However, numerous subsequent
attempts at finding hairless mutations in MUHH repeatedly
failed and it was not until a decade after the initial mapping
of the disease that its underlying cause was finally identified.
Using bioinformatics and sequencing analysis of reverse-
transcriptase–PCR products from A375 and HeLa cell lines,
Wen et al. (2009) discovered the existence of four previously
unknown open reading frames (ORFs) located upstream of
the main hairless ORF, which they named U1HR–U4HR.
ORFs within the 50-untranslated regions of mRNA transcripts
can alter the translational efficiency of the main ORF.
Disruption of upstream ORFs has been reported as the cause
of noncutaneous inherited diseases in humans (Cazzola and
Skoda, 2000). Interestingly, it has been shown in mice that
anagen hair follicles express hairless mRNA but not protein,
suggesting regulation at the translational level (Beaudoin
et al., 2005). Through direct sequencing of all four 50-
untranslated region ORFs in 19 families with MUHH from
different ancestral groups, a total of 13 distinct U2HR single-
nucleotide substitutions were found (Wen et al., 2009).
Functional studies showed that U2HR mutations result in
increased hairless protein expression, leading the authors to
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suggest that a small peptide encoded by wild-type U2HR
decreases the expression of hairless at the translational level
(Wen et al., 2009). Thus, both increased and decreased
hairless activity result in an abnormal hair phenotype,
MUHH and APL, respectively.
Nonsyndromic and syndromic hypotrichoses
Nonsyndromic hypotrichoses form a complex, heteroge-
neous, and clinically challenging group of disorders. The
genetic etiopathogenesis of autosomal recessive hypotricho-
sis started to unfold through the study of two populations
from the Volga–Ural region in Russia, in which a single
deletion in the lipase H (LIPH) gene caused by short
interspersed nuclear element-mediated recombination
(Kazantseva et al., 2006) was found to cause localized
autosomal recessive hypotrichosis type 2 (LAH2; OMIM
604379) (Kazantseva et al., 2006). Subsequent reports
described this and other mutations in LIPH in different
regions of the world in individuals featuring not only
hypotrichosis but also woolly hair (Ali et al., 2007; Nahum
et al., 2009; Shimomura et al., 2009b). The hair growth of
these patients is generally slowed or arrested, which results in
a shortened length of the hair shaft. LIPH encodes a
phospholipase known as lipase H. This enzyme is responsible
for the formation of lysophosphatidic acid (LPA) from
phosphatidic acid. LPA can elicit signal transduction by
binding to the orphan G-protein–coupled receptor, P2Y5
(Pasternack et al., 2009b). Accordingly, localized autosomal
recessive hypotrichosis type 3 (LAH3; OMIM 611452) and
woolly hair were also found to result from mutations in
LPAR6, encoding P2Y5 (Azeem et al., 2008; Pasternack et al.,
2008; 2009a; Shimomura et al., 2008a, 2009a; Tariq et al.,
2009; Horev et al., 2010; Nahum et al., 2011). Taken
together, these data demarcate a critical new pathway of
importance for proper hair growth and structure involving
lipase H, LPA, and its receptor, P2Y5.
Hypotrichosis is not only seen in humans as an isolated
feature but can also be part of complex syndromes. Salient
examples include hypohidrotic ectodermal dysplasia asso-
ciated with mutations in EDA, EDAR, or EDARADD
(Mikkola, 2009), autosomal recessive ichthyosis with hypo-
trichosis (OMIM 610765) associated with mutations in ST14
encoding matriptase (Basel-Vanagaite et al., 2007), alopecia,
neurological defects, and endocrinopathy syndrome (OMIM
612079) associated with mutations in RBM28 (Nousbeck
Figure 2. Clinical classification of inherited alopecias. Hair disorders featuring defective hair growth or differentiation can be classified into three major
types: (a) total absence of hair termed atrichia as shown here in a patient with atrichia with papular lesions (APL); (b) paucity of hair known as
hypotrichosis as shown in a young girl affected with hypotrichosis with juvenile macular dystrophy (HJMD); and (c) diseases caused by abnormal hair
shaft structure such as monilethrix featuring short and easily breakable hair, displaying typical beading under the microscope (lower insert).
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Figure 3. Schematic representation of the hair cycle and hairless mRNA
expression patterns. Two different intensities, low and high, are shown in
dark pink and red, respectively, indicating lower and higher expression of
hairless mRNA during late anagen–catagen–telogen progression in depilation-
induced hair follicle cycling (adapted from Panteleyev et al., 2000 and
Shimomura and Christiano, 2010).
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et al., 2008), Naxos disease associated with mutations in JUP
encoding plakoglobin (Protonotarios and Tsatsopoulou,
2004), and HJMD associated with mutations in CDH3
(Sprecher et al., 2001).
HJMD is transmitted as an autosomal recessive trait and
manifest with sparse and short hair at birth, most probably
due to prolonged telogen (Bergman et al., 2004). These
cutaneous features herald progressive macular degeneration
during the first to second decade of life, culminating with
blindness by 20 years of age. Although some patients with
HJMD display fair hair complexion (Indelman et al., 2003)
and limb abnormalities (Kjaer et al., 2005) (then referred to
as EEM (ectodermal dysplasia, ectrodactyly, and macular
dystrophy syndrome); OMIM 225280), HJMD is often not
distinguishable from other forms of hypotrichosis, and thus
fundus examination and electrophysiological testing are
mandatory in any new case of congenital hypotrichosis.
HJMD-causing mutations in CDH3 result in decreased
expression of P-cadherin, a major constituent of adherens
junctions. Although the role of P-cadherin in maintaining
normal hair growth remains to be fully elucidated, it is
likely to be related to the fact that a large pool of b-catenin,
which serves as a key regulator of hair development, growth,
and differentiation, is normally bound to the cytoplasmic
plaques of adherens junctions (Fuchs, 2007). More recently,
P-cadherin expression was found to be dependent upon
p63 signaling (Shimomura et al., 2008b). These findings
may explain the occasional occurrence of limb abnormalities
in HJMD/EEM syndrome, which are a hallmark of p63
syndromes (Brunner et al., 2002).
As a final note, overlapping clinical manifestations of
mutations affecting distinct genes should always raise the
possibility that the products of these genes may function
along a common biochemical pathway. In this regard, it is
of interest that the P2Y5 receptor, which is defective in
autosomal recessive nonsyndromic hypotrichosis, was shown
to be physiologically expressed in close association with
classical cadherins (Pasternack et al., 2008).
Hair shaft abnormalities
As mentioned above, it is often difficult to draw a clear line
between hypotrichoses and hair shaft disorders, as patients
with diseases primarily resulting from abnormal hair structure
often also manifest clinically with hypotrichosis. As with
atrichias and hypotrichoses, hair shaft disorders can manifest
as solitary diseases or be part of complex constellations
of signs.
Monilethrix can be viewed as a prototypic hair shaft
disorder (Schweizer et al., 2007). Clinically, classical
monilethrix manifests with short and brittle hair, leading to
the clinical appearance of hypotrichosis. In addition, patients
can present additional cutaneous features including nail
dystrophy and follicular papules. Severity is highly variable,
and improvement over time has often been reported. When
inherited as a dominant trait, monilethrix is usually due to
mutations in genes encoding hair keratins, including KRT81,
KRT83, and KRT86 (Winter et al., 1997a, 1997b; van Steensel
et al., 2005). When inherited as a recessive trait, monilethrix
is caused by mutations in DSG4, encoding desmoglein 4
(Schweizer, 2006), unless it is associated with nail dystrophy,
in which case mutations in KRT85 are generally found
(Naeem et al., 2006). DSG4 is localized within the
desmosomal cadherin gene cluster on chromosome 18 and
represents a key mediator of keratinocyte cell adhesion in the
hair follicle. Patients with mutations in DSG4 present with
hair that is typically fragile and prone to break easily, leading
to short sparse scalp hair, as well as to occasional swellings of
the hair shaft (Kljuic et al., 2003).
Syndromic hair shaft disorders encompass a wide range of
inherited syndromes including Netherton syndrome (OMIM
256500) featuring trichorrhexis invaginata, atopy, and
erythroderma, and caused by mutations in SPINK5 (Chavanas
et al., 2000); hypotrichosis with recurrent vesicles (OMIM
613102) associated with mutations in DSC3 (Ayub et al.,
2009); the tricho-hepato-enteric syndrome (OMIM 222470),
characterized by trichorrhexis nodosa, liver disease, and
chronic diarrhea, and caused by mutations in TTC37
(Chavanas et al., 2000; Hartley et al., 2010); and Bjo¨rnstad
syndrome (OMIM 262000). Bjo¨rnstad syndrome remarkably
illustrates the complexity of the molecular genetics of this
group of disorders. The disease is transmitted in an autosomal
recessive manner and features pili torti (1801 twisting of hair
shafts) associated with sensorineural hearing loss (Selvaag,
2000). Bjo¨rnstad syndrome was found to result from
mutations in BCS1L, which encodes a member of the AAA
family of ATPases that are necessary for the assembly of
complex III in the mitochondria. Surprisingly, mutations in
the very same gene also cause complex III deficiency and the
GRACILE (growth retardation, aminoaciduria, cholestasis,
iron overload, lactic acidosis and early death) syndrome
(OMIM 603358), which are lethal conditions characterized
by severe multisystem manifestations (Visapaa et al., 2002;
De Meirleir et al., 2003). How do we explain the fact that
mutations in one same gene lead to such divergent pheno-
types? Whereas Bjo¨rnstad syndrome-associated mutations
only affect residues involved in protein–protein interactions,
mutations causing complex III deficiency alter ATP-binding
residues, resulting in a particularly strong increase in the
production of reactive oxygen species, thus providing the
molecular rationale for the heterogeneous phenotypic mani-
festations of mutations in BCS1L.
FROM GENETICS BACK TO PHENOMICS: TOWARD A
RECLASSIFICATION OF INHERITED HAIR DISORDERS
As briefly outlined above, the past years have witnessed
significant advances in our understanding of the pathogenesis
of genotrichoses. This new knowledge is now resulting in a
reorganization of our classification systems in this group of
diseases, which, instead of being solely founded on clinical
findings, now integrates both clinical and molecular features.
Congenital hypotrichoses epitomize the conceptual changes
derived from these recent findings, and are used here as a
representative example. As demonstrated in Figure 4, it is
now possible to assign most forms of hypotrichosis to one
gene (or group of genes) on the basis of a very limited amount
of information concerning three clinical features: mode of
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inheritance, the presence or absence of associated features,
and microscopic appearance of the hair shaft. Once these
data are available, it is easy to decide about the optimal
molecular diagnostic strategy and genetic testing that is likely
to lead to the correct diagnosis. For example, using the
algorithm outlined in Figure 4, a patient with a dominant
form of hypotrichosis, not associated with any extracutaneous
features and without any evidence for monilethrix under the
microscope, is likely to carry a mutation in either the CDSN
gene, encoding corneodesmosin (Levy-Nissenbaum et al.,
2003), or in the APCDD1 gene, encoding a WNT inhibitor
(Shimomura et al., 2010). In contrast, if a patient is affected
by a recessive form of alopecia and also suffers from nail
dystrophy, then he/she is more likely to carry mutations in the
KRT85 gene (Naeem et al., 2006).
WITHIN A HAIR’S BREADTH FROM THE END: WHAT’S
‘‘NEXT’’ IN GENOTRICHOSES?
The past three decades have demonstrated the formidable
potential of classical linkage and candidate gene approaches.
However, as successful as this strategy has been in leading to
the deciphering of the molecular basis of skin monogenic
disorders, it is not without limitations. Indeed, this methodol-
ogy performs suboptimally under three situations: small-size
families/single individuals, low-penetrance traits, and vary-
ing/subtle phenotypes, complicating the definition of affected
status. These constraints are of little importance in the
presence of an obvious candidate gene, as exemplified by
the identification of a dominant variation in KRT75 conferring
propensity to pseudofolliculitis barbae (Winter et al., 2004).
In other cases, the spectrum of candidate genes can be
narrowed by combining linkage and expression data even
when only few affected individuals are available as recently
demonstrated in a rare form of cutis laxa (Basel-Vanagaite
et al., 2009). However, both in dermatology and in other
fields, the molecular basis of a substantial number of
inherited or congenital disorders remain elusive, highlight-
ing the need for the development of novel technologies
capable of circumventing the weaknesses of currently
available strategies.
Within the past few years, the advent of NGS techniques
has paved the way for genetic investigations that can be
conducted regardless of family structure or trait penetrance. A
full review of the range of equipment systems that are used
today is beyond the scope of the present article and has been
reviewed thoroughly elsewhere (Schadt et al., 2010; Pareek
et al., 2011). It suffices here to state that NGS can be used to
generate large volumes of sequence data, ranging from
discrete genomic regions through exome sequences and up to
the whole genome. The first successful application of exome
sequencing led to the identification of the genetic under-
pinnings of two rare Mendelian disorders: Miller syndrome
(Ng et al., 2010) and Schinzel–Giedion syndrome (Hoischen
et al., 2010). These successes were achieved by massive
parallel sequencing of 180,000 exons across the human
genome. The use of the very same technique recently led to
the identification of a new gene in hypotrichosis simplex. In
this study, Zhou et al. (2011) mapped the disease to a known
gene locus on chromosome 13q12 (Xu et al., 2010) and
studied a single individual by exome target enrichment
and NGS in the linked region. By combining the mapping
and sequencing data, a sequence variant in RPL21, encoding
the ribosomal protein L21, was shown to underlie the disease
(Zhou et al., 2011). Additional examples of the use of NGS in
investigative dermatology include two recent confirmatory
studies implicating genes encoding components of g-secre-
tase in acne inversa (Liu et al., 2011; Pink et al., 2011); the
discovery of the gene associated with terminal osseous
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Figure 4. Clinicogenetic classification of hypotrichoses. Using three clinical criteria, most patients with hypotrichosis can be assigned to a group of
molecularly defined hair disorders. ANE, alopecia, neurological defects, and endocrinopathy; ARIH, autosomal recessive ichthyosis with hypotrichosis;
DSG4, desmoglein 4; ED, ectodermal dysplasia; EDAR, ectodysplasin A receptor; EDARADD, EDAR-associated death domain; HJMD, hypotrichosis with
juvenile macular dystrophy; HRSV, hypotrichosis with recurrent vesicles; KRT85, keratin 85; LIPH, lipase H; LPAR6, lysophosphatidic acid receptor 6;
NTS, Netherton syndrome.
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dysplasia (OMIM 300244; Sun et al., 2010), an X-linked
dominant disease characterized by pigmentary defects of the
skin, skeletal dysplasia of the limbs, and recurrent digital
fibroma; and the deciphering of the molecular etiology of
Clericuzio-type poikiloderma with neutropenia (OMIM
604173; Volpi et al., 2010), a rare autosomal recessive
genodermatosis characterized by poikiloderma, pachyony-
chia, and chronic neutropenia.
A second challenge awaiting the reclassification of
inherited hair disorders is the need to better understand the
pathophysiological relationships between similar or identical
phenotypes resulting from mutations affecting seemingly
distinctive biochemical pathways. We mentioned above the
importance of b-catenin signaling for normal hair growth
(Fuchs, 2007) and its relationship to P-cadherin, which is
defective in HJMD (Sprecher et al., 2001). P-cadherin is a
major component of adherens junctions and colocalizes with
the P2RY5 receptor, which is defective in LAH3 (Pasternack
et al., 2008). Recent data indicate that the VDR, which has
been linked to the pathogenesis of APL (Skorija et al., 2005),
costimulates b-catenin signaling (Larriba et al., 2007). On the
other hand, hairless, which interacts with VDR (Hsieh et al.,
2003) and is defective in APL, was found to regulate the
expression of ornithine decarboxylase, as well as of an
inhibitor of WNT signaling (Thompson et al., 2006), which in
turn controls the intracytoplasmic levels of b-catenin
(Figure 5).
As anticipated as functional relationships between systems
implicated in the pathogenesis of phenotypically related
disorders can be, they will have to be delineated in details as
they point to common regulatory pathways easily targetable
for the treatment of inherited, and possibly acquired,
hair disorders. Indeed, the translation of the new findings
reviewed over these pages into innovative therapeutic
strategies should be regarded as one of our most important
goals. Initial steps in that direction have already been taken.
For example, we mentioned the new pathway recently
uncovered through the study of rare forms of hypotrichosis,
which involves lipase H, LPA, and its receptor, P2RY5
(Kazantseva et al., 2006; Pasternack et al., 2008; Shimomura
et al., 2008a). The delineation of such a new pathway clearly
offers new possibilities for therapeutic interventions aimed at
inhibiting or promoting hair growth. In this regard, it is of
interest to note that LPA has already been shown to stimulate
hair growth in mice (Takahashi et al., 2003). Similarly,
selective inhibition of the hairless protein has been shown to
lead to decreased hair growth (Cserhalmi-Friedman et al.,
2004), a finding that may form the basis for a new approach
to the treatment of diseases as common as female hirsutism.
In summary, 15 years after the identification of the first
skin disease–causing mutations in humans (Ballabio et al.,
1987; Yen et al., 1987), it is evident that the study of
cutaneous monogenic disorders has had an enormous impact
within and outside our field, not only broadening our
understanding of hair biology, but, more importantly, paving
the way for improved diagnosis, and prevention and
treatment of skin diseases, inherited and acquired alike.
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